| Title: |
285 Phase I clinical trial evaluating the safety of ADP-A2M10 in patients with MAGE-A10+ head and neck, melanoma, or urothelial tumors |
| Authors: |
Marcus Butler, David Hong, Ryan Sullivan, Matthew Frigault, Sarah Boross-Harmer, Ecaterina Dumbrava, Jean-Marc Navenot, Svetlana Fayngerts, Jane Bai, Elliot Norry, Paula Fracasso, Russell Pachynski, Partow Kebriaei, Amy Sauer, Francine Brophy |
| Source: |
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020) |
| Publisher Information: |
BMJ Publishing Group, 2020. |
| Publication Year: |
2020 |
| Collection: |
LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
| Subject Terms: |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282 |
| Document Type: |
article |
| File Description: |
electronic resource |
| Language: |
English |
| ISSN: |
2051-1426 |
| Relation: |
https://doaj.org/toc/2051-1426 |
| DOI: |
10.1136/jitc-2020-SITC2020.0285 |
| Access URL: |
https://doaj.org/article/3cc3704b6a2e45a5bc9da899afd13797 |
| Accession Number: |
edsdoj.3cc3704b6a2e45a5bc9da899afd13797 |
| Database: |
Directory of Open Access Journals |
